PSTX - Poseida Therapeutics GAAP EPS of -$0.39 misses by $0.56 revenue of $10.05M misses by $21.7M
2023-03-09 17:56:27 ET
- Poseida Therapeutics press release ( NASDAQ: PSTX ): Q4 GAAP EPS of -$0.39 misses by $0.56 .
- Revenue of $10.05M (-67.8% Y/Y) misses by $21.7M .
For further details see:
Poseida Therapeutics GAAP EPS of -$0.39 misses by $0.56, revenue of $10.05M misses by $21.7M